TONIX Pharmaceuticals, Inc. Completes $1 Million Financing With Technology Partners
12/27/2012 9:58:28 AM
More...
|
TONIX Pharmaceuticals, Inc. Completes Pre-IND Meeting With FDA for Potential New Treatment for Post-Traumatic Stress Disorder
10/24/2012 8:48:10 AM
More...
|
TONIX Pharmaceuticals, Inc. Confirms Clinical Utility of TNX-102 Sublingual Tablet
10/23/2012 8:53:39 AM
More...
|
TONIX Pharmaceuticals, Inc. to Present at 2012 AEGIS Healthcare Conference
9/24/2012 9:02:20 AM
More...
|
TONIX Pharmaceuticals, Inc. Highlights Therapeutic Programs on CEONEWS.Tv
9/20/2012 9:15:04 AM
More...
|
TONIX Pharmaceuticals, Inc. Announces Poster Presentation at the 2012 American College of Rheumatology Annual Scientific Meeting
9/19/2012 8:30:23 AM
More...
|
TONIX Pharmaceuticals, Inc. to Present at Rodman & Renshaw 14th Annual Global Investment Conference on September 11
9/5/2012 8:58:53 AM
More...
|
TONIX Pharmaceuticals, Inc.' CEO Highlights Connection Between Disturbed Sleep and New Treatment for Fibromyalgia and Post-Traumatic Stress Disorder on KIDELA TV
8/27/2012 9:18:58 AM
More...
|
TONIX Pharmaceuticals, Inc. Issues Letter to Shareholders
8/21/2012 9:19:22 AM
More...
|
TONIX Pharmaceuticals, Inc. CEO Dr. Seth Lederman Describes Potential Treatment for Fibromyalgia, Post-Traumatic Stress Disorder and Traumatic Brain Injury
8/16/2012 9:46:25 AM
More...
|
|